Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy

A Study of TAK-861 in People With Narcolepsy Type 1

NCT06505031 ·Status: COMPLETED ·Phase: PHASE3

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

NCT04096560 ·Status: TERMINATED ·Phase: PHASE2

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy

NCT02806908 ·Status: COMPLETED ·Phase: PHASE2

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

NCT04923594 ·Status: COMPLETED ·Phase: PHASE2

A Study of TAK-994 in Adults With Narcolepsy

NCT04820842 ·Status: TERMINATED ·Phase: PHASE2

A Study of TAK-861 in Participants With Narcolepsy Type 2

NCT05687916 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

NCT00049803 ·Status: COMPLETED ·Phase: PHASE3

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

NCT02720744 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

NCT01067222 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

NCT01067235 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

NCT02215499 ·Status: COMPLETED ·Phase: PHASE1

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1

NCT05914194 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Narcolepsy - New Potential Treatment

NCT02077036 ·Status: UNKNOWN ·Phase: NA

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

NCT00389831 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study of FT218 in Subjects With Narcolepsy

NCT04451668 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

NCT05113745 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

NCT04886518 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

NCT05055024 ·Status: COMPLETED ·Phase: PHASE2

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

NCT03433131 ·Status: NO_LONGER_AVAILABLE

Effect of Nicotinamide in Friedreich's Ataxia

NCT01589809 ·Status: UNKNOWN ·Phase: PHASE2

A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)

NCT01146951 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension

NCT04257929 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

NCT00225862 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

NCT04539041 ·Status: COMPLETED ·Phase: PHASE1

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

NCT00051961 ·Status: COMPLETED